Joint Fellowship Training Program

Mentors

Steven R. Bauer, Ph.D.
Biologist, Laboratory of Stem Cell Biology, Division of Cell and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration
steven.bauer@fda.hhs.gov

Andrew P. Byrnes, PhD
Principle Investigator, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research
andrew.byrnes@fda.hhs.gov

Mona S. Calvo, Ph.D.
Expert Regulatory Review Scientist, Nutritionist Division of Toxicology, Office of Applied Research and Safety Assessment (OARSA), Center for Food Safety and Applied Nutrition (CFSAN), FDA
mona.calvo@fda.hhs.gov

Rosalie K. Elespuru, PhD
Biologist, Genomics & Genetics Laboratory, Division of Biology, Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiologic Health (CDRH), FDA
rosalie.elespuru@fda.hhs.gov

Stephen Feinstone, M.D.
Chief, Laboratory of Hepatitis Viruses, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research (CBER), FDA
stephen.feinstone@fda.hhs.gov

Brandon D. Gallas, Ph.D.
Mathematician, Division of Imaging and Applied Mathematics (DIAM), Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), FDA
brandon.gallas@fda.hhs.gov

Indira Hewlett, Ph.D
Chief, Laboratory of Molecular Virology, Division of Emerging and Transfusion Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), FDA
indira.hewlett@fda.hhs.gov

Deborah A. Hursh, PhD
Principle Investigator, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research (CBER), FDA
deborah.hursh@fda.hhs.gov

Gibbes Johnson, Ph.D., (Chief), and Ying-Xin Fan, Ph.D.
Laboratory of Chemistry, Division of Therapeutic Proteins, Office of Biotechnology Products, Office of Pharmaceutical Sciences, Center for Drug Evaluation and Research (CDER), FDA
gibbes.johnson@fda.hhs.gov
ying-xin.fan@fda.hhs.gov

Claudine J. Kavanaugh, Ph.D., MPH, RD
Biologist, Division of Nutritional Labeling and Products, Office of Nutritional Labeling Products and Dietary Supplements, Center for Food Safety and Applied Nutrition (CFSAN), FDA
claudine.kavanaugh@fda.hhs.gov

Gerald E Marti, M.D., Ph.D.
Medical Officer and Research-Regulatory Scientist, Cellular and Tissue Therapy Branch, Division of Cellular and Gene Therapies, Center for Biologis Evaluation and Research (CBER), FDA
gerald.marti@fda.hhs.gov

Kyle J. Myers, Ph.D.
Laboratory Leader, Medical Imaging and Diagnostics Laboratory, Division of Imaging and Applied Mathematics (DIAM), Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), FDA
kyle.myers@fda.hhs.gov

Akhilesh K. Nagaich, Ph.D
Senior Staff Fellow, Laboratory of Chemistry, Division of Therapeutic Proteins, Office of Biotechnology Products, Office of Pharmaceutical Sciences, Center for Drug Evaluation and Research, FDA
akhilesh.nagaich@fda.hhs.gov

Michael D. O'Hara, Ph.D.
FDA Staff Fellow, Radiation Biologist, Laboratory of Radiation Bioeffects, Division of Biology, Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), FDA
michael.ohara@fda.hhs.gov

Keith Peden, Ph.D.
Senior Investigators, Division of Viral Products (DVP) Office of Vaccines Research and Review (OVRR), Center for Biologics Evaluation and Research (CBER), FDA
keith.peden@fda.hhs.gov

Ashutosh Rao, R.Ph., Ph.D.
Staff Fellow, Laboratory of Biochemistry, Division of Therapeutic Proteins, Office of Biotechnology Products, Office of Pharmaceutical Science, Center for Drug Evaluation and Research (CDER), FDA
ashutosh.rao@fda.hhs.gov

Barbara L. Rellahan, Ph.D.
Principal Investigator, Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation Research, FDA
barbara.rellahan@fda.hhs.gov

Emily Shacter, Ph.D.
Chief, Laboratory of Biochemistry, Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA
emily.shacter@fda.hhs.gov

Jan Simak, Ph.D.
Visiting Scientist, Laboratory of Cellular Hematology, Division of Hematology, Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), FDA
jan.simak@fda.hhs.gov

Mate Tolnay, Ph.D.
Principal Investigator, Laboratory of Molecular and Developmental Immunology, Division of Monoclonal Antibodies, Office of Biotechnology Products, Center of Drug Evaluation and Research, Food and Drug Administration
mate.tolnay@fda.hhs.gov

Wendy C. Weinberg, Ph.D.
Principal Investigator, Division of Monoclonal Antibodies, Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), FDA
wendy.weinberg@fda.hhs.gov

Carolyn A. Wilson, Ph.D.
Senior Investigator in the Laboratory of Immunology and Virology, Division of Cellular and Gene Therapy, Office of Cells, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), FDA
carolyn.wilson@fda.hhs.gov

Wen Jin Wu, M.D./Ph.D.
Principal Investigator, Division of Monoclonal Antibodies (DMA), Office of Biotechnology Products (OBP), Office of Pharmaceutical Science (OPS), Center for Drug Evaluation and Research (CDER), FDA
wen.wu@fda.hhs.gov

Baolin Zhang, Ph.D.
Principal Investigator, Lab. of Biochemistry, Division of Therapeutic Proteins (DTP), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), FDA
baolin.zhang@fda.hhs.gov